High prevalence of CNS-directed autoantibodies in patients with schizophrenia
Katlyn Nemani, Jillian R. Jaycox, Uğur Akcan…·Aaron M. Ring
This study identifies a high prevalence of CNS-directed autoantibodies in schizophrenia patients, linking them to disease severity, treatment resistance, and potential therapeutic targets.